SCHEDULE: RTW Investments Discloses 9.4% Stake in uniQure N.V.
Beneficial Ownership Report
RTW Investments, LP and Roderick Wong, M.D. have disclosed a 9.4% beneficial ownership stake in uniQure N.V.'s Ordinary Shares.
Summary
- RTW Investments, LP and Roderick Wong, M.D. are the reporting persons.
- They collectively beneficially own 5,158,231 Ordinary Shares of uniQure N.V.
- This ownership represents 9.4% of uniQure N.V.'s Ordinary Shares outstanding.
- The percentage is calculated based on 54,865,673 shares outstanding as of June 30, 2025, as reported in uniQure N.V.'s Form 10-Q filed on July 29, 2025.
- The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The disclosure of a significant 9.4% passive stake by a reputable investment firm like RTW Investments is generally viewed as a positive signal of confidence in the company's long-term prospects, although the filing itself is a factual disclosure without explicit sentiment.
Future Outlook
NA
Management Comments
- The securities referred to were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.
Industry Context
This filing indicates a significant passive investment by a specialized healthcare investment firm in a biotechnology company. Such disclosures are common for institutional investors taking substantial positions in publicly traded companies, particularly within the life sciences sector where long-term investment horizons are typical.
Stakeholder Impact
- Shareholders: Increased institutional ownership may be viewed positively, potentially signaling confidence in the company's value and future performance.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement. |
| 07/29/2025 | Date uniQure N.V. filed its Quarterly Report on Form 10-Q, reporting shares outstanding. |
| 08/14/2025 | Date of filing/signature of this Schedule 13G Amendment No. 1. |
Keywords
uniQure N.V., RTW Investments, Roderick Wong, Beneficial Ownership, SEC Filing, Schedule 13G, Biotechnology, Investment Adviser, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.